# Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD (BS8X)

**Page:** https://fundology.uk/fund/bs8x · ISIN IE000GMRDSZ7

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 16/11/2026, BS8X (Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD, ISIN IE000GMRDSZ7) closed at £4.43 on the London Stock Exchange. Its ongoing charge is 0.10% a year (about £10 on £10,000). Over the year to 16/11/2026 its total return was +2.1%, or −1.6% after UK CPIH inflation.

## Summary

Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD is an exchange-traded fund (ETF) from Invesco, launched in 2024. It tracks the Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.1% a year — about £10 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

Latest close: **£4.43** (16/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | BS8X |
| ISIN | IE000GMRDSZ7 |
| Also listed as | BS8A (London Stock Exchange, US dollars) |
| Category | Corporate & other bonds |
| Type | ETF |
| Provider | Invesco |
| Tracks | Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net |
| Income | Accumulating |
| Ongoing charge | 0.10% a year (£10 per £10,000) |
| Fund size | £15.0m |
| Launched | 2024 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 21/05/2024 |

## Past returns (periods to 16/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +2.05% | -1.56% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD in pounds (price, with income reinvested in the fund): 2025 −1.6%; 2026 to 13/11/2026 +3.5%. Returns of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +3.6%; to 30/09/2025: +4.2%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2025 | -1.6% | -5.0% | Price |
| 2026 to 13/11/2026 | +3.5% | +0.2% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 5.16% | -3.67% |

## Largest fall

Volatility of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD in pounds, annualised from weekly returns to 13/11/2026: 5.2% over 1 year. Largest fall in the price of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD since May 2024, in pounds: −7.8% from 17/01/2025 to 27/06/2025. The lowest 12-month return of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD in pounds (price, with income reinvested in the fund) since May 2024 was −3.5% (12 months to 30/01/2026); the highest was +8.0% (12 months to 26/06/2026). On 13/11/2026 the price of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD was 0.1% below its highest weekly close since May 2024 (17/01/2025), in pounds.

## Charges compared with similar funds

Ongoing charge of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD 0.10% a year. Compared on 16/11/2026, 386 of the 430 other corporate and other bond funds charge more, 26 the same and 18 less (share classes counted once).

## Funds tracking the same index

3 funds track Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net, this one included and share classes counted once; their ongoing charges range from 0.10% to 0.16% a year (16/11/2026).

| Fund | Ongoing charge | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- Hedged GBP | 0.12% | +1.4% | — | — |
| Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD (this fund) | 0.10% | +2.1% | — | — |
| Invesco Markets II plc - Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Hedged GBP | 0.16% | +2.3% | — | — |

Returns are as reported, in pounds, income reinvested unless marked "(price)".

## Charges & eligibility

- Ongoing charges figure (OCF): **0.10%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 12/11/2026, BS8X holds 602 positions, according to its published holdings. The largest is Pfizer Investment Enterprises Pte 4.45% 19/05/28 at 1.06% of the fund; the ten largest make up 7.6%.

### Top holdings

Largest positions (as of 12/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Pfizer Investment Enterprises Pte 4.45% 19/05/28 | — | 1.06% |
| 2 | CVS Health Corp 4.3% 25/03/28 | — | 0.98% |
| 3 | Salesforce Inc 4.5% 15/03/28 | — | 0.75% |
| 4 | Cigna Group/The 4.375% 15/10/28 | — | 0.74% |
| 5 | Comcast Corp 4.15% 15/10/28 | — | 0.71% |
| 6 | Amgen Inc 5.15% 02/03/28 | — | 0.70% |
| 7 | AerCap Ireland Capital DAC / AerCa 3% 29/10/28 | — | 0.69% |
| 8 | NVIDIA Corp 4.25% 15/06/28 | — | 0.69% |
| 9 | Sumitomo Mitsui Financial Group In 5.52% 13/01/28 | — | 0.68% |
| 10 | Morgan Stanley VAR 22/07/28 | — | 0.62% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By type of asset

Added up from the fund’s published holdings, as of 05/11/2026.

| Type of asset | Weight |
|---|---|
| Bonds | 99.8% |
| Cash and money market | 0.2% |

All 602 holdings: https://fundology.uk/fund/bs8x/holdings

## Questions people ask

**What is the ongoing charge of BS8X?**

The ongoing charge of BS8X is 0.10% a year — about £10 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD 0.10% a year. Compared on 16/11/2026, 386 of the 430 other corporate and other bond funds charge more, 26 the same and 18 less (share classes counted once).

**What does BS8X track?**

BS8X tracks the Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net.

**Is BS8X accumulating or distributing?**

BS8X is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.

**What is the ISIN of BS8X?**

The ISIN of BS8X is IE000GMRDSZ7. An ISIN identifies one exact share class of a fund; BS8X is its ticker on the London Stock Exchange. The same share class is also listed as BS8A (London Stock Exchange, US dollars).

**What does BS8X hold?**

As of 12/11/2026, BS8X holds 602 positions, according to its published holdings. The largest is Pfizer Investment Enterprises Pte 4.45% 19/05/28 at 1.06% of the fund; the ten largest make up 7.6%. Its ten largest holdings are Pfizer Investment Enterprises Pte 4.45% 19/05/28 (1.06%), CVS Health Corp 4.3% 25/03/28 (0.98%), Salesforce Inc 4.5% 15/03/28 (0.75%), Cigna Group/The 4.375% 15/10/28 (0.74%), Comcast Corp 4.15% 15/10/28 (0.71%), Amgen Inc 5.15% 02/03/28 (0.70%), AerCap Ireland Capital DAC / AerCa 3% 29/10/28 (0.69%), NVIDIA Corp 4.25% 15/06/28 (0.69%), Sumitomo Mitsui Financial Group In 5.52% 13/01/28 (0.68%) and Morgan Stanley VAR 22/07/28 (0.62%).

**What were BS8X’s returns in each of the last five years?**

Calendar-year returns of BS8X in pounds (price, with income reinvested in the fund): 2025 −1.6%; 2026 to 13/11/2026 +3.5%. Past performance is not a guide to future returns.

**How has BS8X done after inflation?**

Over the year to 16/11/2026 BS8X’s total return was +2.1%, or −1.6% after UK CPIH inflation. Past performance is not a guide to future returns.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.
